D.E. Shaw & Co
AKYA

D.E. Shaw & Co’s Akoya BioSciences AKYA Stock Holding History

D.E. Shaw & Co’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,370
Closed -$45.3K – 4504
2024
Q2 		$45.3K Buy
+19,370
New +$61.8K ﹤0.01% 4223
2021
Q3 		– Sell
-14,309
Closed -$277K – 4931
2021
Q2 		$277K Buy
+14,309
New +$295K ﹤0.01% 4317

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

D.E. Shaw & Co's AKYA Position: Q3 2024 in Review

D.E. Shaw & Co sold out of Akoya BioSciences (AKYA) in Q3 2024, closing a stake of 19,370 shares — an estimated $45.3K sold.

D.E. Shaw & Co first reported a position in AKYA in Q2 2021 and held it in 2 quarters. The position peaked at $277K in Q2 2021. 59 funds tracked by Wall St. Rank hold AKYA as of Q3 2024.

  • D.E. Shaw & Co reported no remaining Akoya BioSciences position as of Q3 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 19,370 Akoya BioSciences shares in Q3 2024, an estimated $45.3K.
  • D.E. Shaw & Co first reported a position in Akoya BioSciences in Q2 2021 and held it in 2 quarters.
  • D.E. Shaw & Co's Akoya BioSciences position peaked at $277K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.